The use of analgesic medicine in Australia is projected to decline significantly from 2023 to 2027. In 2023, the actual usage stood at 11.6 Defined Daily Dosage (DDD) per thousand persons per day. However, forecasted data indicates a downward trend in the following years, with usage expected to fall to 10.3 in 2024, 9.1 in 2025, 7.9 in 2026, and 6.7 in 2027.
- Year-on-year variation from 2023 to 2024 shows a decrease of approximately 11.2%.
- Year-on-year variation from 2024 to 2025 indicates a decline of around 11.7%.
- Year-on-year variation from 2025 to 2026 reveals a decrease of about 13.2%.
- Year-on-year variation from 2026 to 2027 shows a reduction of around 15.2%.
The Compound Annual Growth Rate (CAGR) over the last 5 years reflects an average annual decline rate of approximately 12.9%.
Future trends to watch for include potential changes in healthcare policies, the impact of alternative pain management therapies, and public awareness on the risks of long-term analgesic use. Monitoring these factors could provide insight into the sustainability of the projected decline in analgesic medicine usage.
